259 related articles for article (PubMed ID: 11817598)
21. Autosomal-dominant periodic fever with AA amyloidosis: Novel mutation in tumor necrosis factor receptor 1 gene Rapid Communication.
Jadoul M; Dodé C; Cosyns JP; Abramowicz D; Georges B; Delpech M; Pirson Y
Kidney Int; 2001 May; 59(5):1677-82. PubMed ID: 11318938
[TBL] [Abstract][Full Text] [Related]
22. An autosomal dominant periodic fever associated with AA amyloidosis in a north Indian family maps to distal chromosome 1q.
McDermott MF; Aganna E; Hitman GA; Ogunkolade BW; Booth DR; Hawkins PN
Arthritis Rheum; 2000 Sep; 43(9):2034-40. PubMed ID: 11014353
[TBL] [Abstract][Full Text] [Related]
23. Novel mutations in TNFRSF1A in patients with typical tumor necrosis factor receptor-associated periodic syndrome and with systemic lupus erythematosus in Japanese.
Horiuchi T; Tsukamoto H; Mitoma H; Miyagawa H; Tamimoto Y; Yoshizawa S; Harada M; Hayashi K; Hashimura C; Oribe M; Okamura S
Int J Mol Med; 2004 Nov; 14(5):813-8. PubMed ID: 15492850
[TBL] [Abstract][Full Text] [Related]
24. Two familial cases with tumor necrosis factor receptor-associated periodic syndrome caused by a non-cysteine mutation (T50M) in the TNFRSF1A gene associated with severe multiorganic amyloidosis.
Kallinich T; Briese S; Roesler J; Rudolph B; Sarioglu N; Blankenstein O; Keitzer R; Querfeld U; Haffner D
J Rheumatol; 2004 Dec; 31(12):2519-22. PubMed ID: 15570662
[TBL] [Abstract][Full Text] [Related]
25. A novel mutation in the third extracellular domain of the tumor necrosis factor receptor 1 in a Finnish family with autosomal-dominant recurrent fever.
Nevala H; Karenko L; Stjernberg S; Raatikainen M; Suomalainen H; Lagerstedt A; Rauta J; McDermott MF; Peterson P; Pettersson T; Ranki A
Arthritis Rheum; 2002 Apr; 46(4):1061-6. PubMed ID: 11953985
[TBL] [Abstract][Full Text] [Related]
26. Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.
Todd I; Radford PM; Draper-Morgan KA; McIntosh R; Bainbridge S; Dickinson P; Jamhawi L; Sansaridis M; Huggins ML; Tighe PJ; Powell RJ
Immunology; 2004 Sep; 113(1):65-79. PubMed ID: 15312137
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) or familial Hibernian fever: presentation in a four-day-old infant.
Savage T; Loftus BG; Tormey V; McDermott MF; Moylett E
J Clin Rheumatol; 2008 Dec; 14(6):342-5. PubMed ID: 18690165
[TBL] [Abstract][Full Text] [Related]
28. [A Dutch family with the hereditary periodic fever or tumour necrosis factor receptor-associated periodic syndrome (TRAPS)].
Chang Pan Huo NM; Dankert-Roelse JE; Kwee ML
Ned Tijdschr Geneeskd; 2006 Dec; 150(49):2711-4. PubMed ID: 17194009
[TBL] [Abstract][Full Text] [Related]
29. A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) manifesting adult-onset Still disease-like skin eruptions: report of a case and review of the Japanese patients.
Nakamura M; Kobayashi M; Tokura Y
Br J Dermatol; 2009 Oct; 161(4):968-70. PubMed ID: 19673872
[No Abstract] [Full Text] [Related]
30. Role of the R92Q TNFRSF1A mutation in patients with familial Mediterranean fever.
Marek-Yagel D; Berkun Y; Padeh S; Lidar M; Shinar Y; Bar-Joseph I; Reznik-Wolf H; Langevitz P; Livneh A; Pras E
Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1294-8. PubMed ID: 20506103
[TBL] [Abstract][Full Text] [Related]
31. A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with high serum interleukin (IL)-22.
Nakamura M; Tokura Y
Eur J Dermatol; 2010; 20(4):508-9. PubMed ID: 20400394
[No Abstract] [Full Text] [Related]
32. Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line.
Rebelo SL; Amel-Kashipaz MR; Radford PM; Bainbridge SE; Fiets R; Fang J; McDermott EM; Powell RJ; Todd I; Tighe PJ
Arthritis Rheum; 2009 Jan; 60(1):269-80. PubMed ID: 19116900
[TBL] [Abstract][Full Text] [Related]
33. Incidence of TNFRSF1A mutations in German children: epidemiological, clinical and genetic characteristics.
Lainka E; Neudorf U; Lohse P; Timmann C; Stojanov S; Huss K; von Kries R; Niehues T
Rheumatology (Oxford); 2009 Aug; 48(8):987-91. PubMed ID: 19541728
[TBL] [Abstract][Full Text] [Related]
34. [From gene to disease; tumor necrosis factor receptor and a syndrome of familial periodic fever].
Simon A; Drenth JP; van der Meer JW
Ned Tijdschr Geneeskd; 2001 Jan; 145(2):77-8. PubMed ID: 11225261
[TBL] [Abstract][Full Text] [Related]
35. Monocytic fasciitis: a newly recognized clinical feature of tumor necrosis factor receptor dysfunction.
Hull KM; Wong K; Wood GM; Chu WS; Kastner DL
Arthritis Rheum; 2002 Aug; 46(8):2189-94. PubMed ID: 12209524
[TBL] [Abstract][Full Text] [Related]
36. Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A.
Nowlan ML; Drewe E; Bulsara H; Esposito N; Robins RA; Tighe PJ; Powell RJ; Todd I
Rheumatology (Oxford); 2006 Jan; 45(1):31-7. PubMed ID: 16287931
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes.
Waschke KA; Villani AC; Vermeire S; Dufresne L; Chen TC; Bitton A; Cohen A; Thomson AB; Wild GE
Am J Gastroenterol; 2005 May; 100(5):1126-33. PubMed ID: 15842589
[TBL] [Abstract][Full Text] [Related]
38. Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome.
Nedjai B; Hitman GA; Quillinan N; Coughlan RJ; Church L; McDermott MF; Turner MD
Arthritis Rheum; 2009 Feb; 60(2):619-25. PubMed ID: 19180495
[TBL] [Abstract][Full Text] [Related]
39. Identification of a novel mevalonate kinase gene mutation in combination with the common MVK V377I substitution and the low-penetrance TNFRSF1A R92Q mutation.
Hoffmann F; Lohse P; Stojanov S; Shin YS; Renner ED; Kéry A; Zellerer S; Belohradsky BH
Eur J Hum Genet; 2005 Apr; 13(4):510-2. PubMed ID: 15657603
[TBL] [Abstract][Full Text] [Related]
40. Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications.
D'Osualdo A; Ferlito F; Prigione I; Obici L; Meini A; Zulian F; Pontillo A; Corona F; Barcellona R; Di Duca M; Santamaria G; Traverso F; Picco P; Baldi M; Plebani A; Ravazzolo R; Ceccherini I; Martini A; Gattorno M
Arthritis Rheum; 2006 Mar; 54(3):998-1008. PubMed ID: 16508982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
